Home > Annual Financials > BROOKS LABORATORIES

BROOKS LABORATORIES Financial Statement Analysis
[BOM: 533543|NSE : BROOKS]

The Revenues of BROOKS LABORATORIES have decreased by -30.68% YoY .
The Earnings Per Share (EPS) of BROOKS LABORATORIES has decreased by Negative YoY.
REVENUES
OPERATING MARGIN
PROFIT AFTER TAX
EPS
ROCE

BROOKS LABORATORIES Last 5 Annual Financial Results
[BOM: 533543|NSE : BROOKS]

ConsolidatedMar2024
Mar2023
Mar2022
Mar2021
Revenues ₹63 Cr₹91 Cr₹77 Cr₹77 Cr
Expenses ₹90 Cr₹105 Cr₹77 Cr₹77 Cr
Operating Profit (Excl OI) ₹-26 Cr₹-14 Cr₹0.52 Cr₹0.52 Cr
Other Income ₹0.21 Cr₹0.80 Cr₹0.74 Cr₹0.74 Cr
Interest ₹2.18 Cr₹3.10 Cr₹3.10 Cr₹3.10 Cr
Depreciation ₹7.03 Cr₹7.35 Cr₹7.14 Cr₹7.14 Cr
Profit Before Tax ₹-38 Cr₹-24 Cr₹-8.99 Cr₹-8.99 Cr
Profit After Tax ₹-31 Cr₹-19 Cr₹-19 Cr₹-19 Cr
Consolidated Net Profit ₹-21 Cr₹-11 Cr₹-19 Cr₹-19 Cr
Earnings Per Share (Rs)₹-7.46₹-8.46₹-4.57₹-7.84
PAT Margin (%)-24.65-49.12-21.18-25.08
ROE(%)-28.08-38.46-23.18-24.48
ROCE(%)-24.92-37.83-18.72-5.33
Total Debt/Equity(x)0.080.080.280.40

Key Financials

Market Cap : ₹ 451.0 Cr
Revenue (TTM) : ₹ 78.2 Cr
Net Profit(TTM) : ₹ 1.6 Cr
EPS (TTM) : ₹ 0.6
P/E (TTM) : 277.7

Industry Peers & Returns1W1M1Y
BROOKS LABORATORIES 8.2% 19.7% 27.4%
SUN PHARMACEUTICAL INDUSTRIES 1% 0.7% 47.3%
CIPLA 0.3% -1.8% 19.6%
DR REDDYS LABORATORIES 6% 11.8% 20.3%
ZYDUS LIFESCIENCES -1.5% -0.1% 47%
DIVIS LABORATORIES -1.1% -5.8% 61.7%
MANKIND PHARMA 3.7% 11.4% 59.4%
TORRENT PHARMACEUTICALS 0.6% 4.1% 59.5%
LUPIN 3.3% 2.9% 75.9%


BROOKS LABORATORIES Revenues
[BOM: 533543|NSE : BROOKS]

Y-o-Y

-30.68 %

5 Yr CAGR

-6.47 %

Years Revenues % Change
Mar2024 ₹63 Cr
-30.68
Mar2023 ₹91 Cr
18.04
Mar2022 ₹77 Cr
0.00
Mar2021 ₹77 Cr -


BROOKS LABORATORIES Operating Profit
[BOM: 533543|NSE : BROOKS]

Y-o-Y

Negative

5 Yr CAGR

Negative

Years Operating Profit % Change
Mar2024 ₹-26 Cr
Negative
Mar2023 ₹-14 Cr
Negative
Mar2022 ₹0.52 Cr
0.00
Mar2021 ₹0.52 Cr -

Operating Margins
Y-o-Y

Negative

5 Yr CAGR

Negative

Years Operating Margin% % Change
Mar2024 -41.8%
Negative
Mar2023 -15.63%
Negative
Mar2022 0.67%
0.00
Mar2021 0.67% -

BROOKS LABORATORIES Profit After Tax
[BOM: 533543|NSE : BROOKS]

Y-o-Y

Negative

5 Yr CAGR

Negative

Years Profit After Tax % Change
Mar2024 ₹-21 Cr
Negative
Mar2023 ₹-11 Cr
Negative
Mar2022 ₹-19 Cr
Negative
Mar2021 ₹-19 Cr -

PAT Margins
Y-o-Y

Negative

5 Yr CAGR

Negative

Years PAT Margin(%) % Change
Mar2024 -24.65 %
Negative
Mar2023 -49.12 %
Negative
Mar2022 -21.18 %
Negative
Mar2021 -25.08 % -

BROOKS LABORATORIES Earnings Per Share (EPS)
[BOM: 533543|NSE : BROOKS]

Y-o-Y

Negative

5 Yr CAGR

Negative

Years EPS % Change
Mar2024 ₹-7.46
Negative
Mar2023 ₹-8.46
Negative
Mar2022 ₹-4.57
Negative
Mar2021 ₹-7.84 -

BROOKS LABORATORIES Return on Capital Employed (ROCE)
[BOM: 533543|NSE : BROOKS]

Y-o-Y

Negative

5 Yr CAGR

Negative

Years ROCE % Change
Mar2024 -24.92%
Negative
Mar2023 -37.83%
Negative
Mar2022 -18.72%
Negative
Mar2021 -5.33% -

BROOKS LABORATORIES Share Price vs Sensex

Current Share Price : ₹172.2
Current MarketCap: ₹ 451.0 Cr
Updated EOD on :Dec 24,2024

Share Price Returns(%) 1 Week 1 Month 1 Year
BROOKS LABORATORIES

8.2%

19.7%

27.4%

SENSEX

-2.7%

-0.8%

9.9%

BROOKS LABORATORIES related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about BROOKS LABORATORIES Financials


How the annual revenues of BROOKS LABORATORIES have changed ?

The Revenues of BROOKS LABORATORIES have decreased by -30.68% YoY .

How the Earnings per Share (EPS) of BROOKS LABORATORIES have changed?

The Earnings Per Share (EPS) of BROOKS LABORATORIES has decreased by Negative YoY .